Jones Financial Companies Lllp Lexicon Pharmaceuticals, Inc. Transaction History
Jones Financial Companies Lllp
- $105 Billion
- Q4 2024
A detailed history of Jones Financial Companies Lllp transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 142 shares of LXRX stock, worth $96. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142Holding current value
$96% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
141Shares Held
240MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$92.6 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$26.5 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$7.5 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$6.73 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$6.72 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $128M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...